ImmunityBio, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
ImmunityBio, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2014 to Q3 2024.
  • ImmunityBio, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending September 30, 2024 was $4.18M.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.18M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.03M Jun 30, 2024 10-Q 2024-08-12
Q4 2023 $0 Dec 31, 2023 10-Q 2024-11-12
Q2 2015 $45K Jun 30, 2015 10-Q 2015-09-10
Q4 2014 $145K Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.